PHARMACIE FUGERAY - PAGE is a French company
founded 18 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SOUPPES-SUR-LOING (77460),
this company of category PME
shows in 2023 a revenue of 2.7 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE FUGERAY - PAGE (SIREN 502837479)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
2 710 286 €
2 668 673 €
N/C
N/C
1 955 221 €
2 604 691 €
2 557 907 €
2 643 627 €
Net income
169 807 €
230 053 €
386 745 €
385 119 €
339 813 €
275 453 €
361 186 €
345 302 €
324 230 €
EBITDA
N/C
309 663 €
387 148 €
N/C
N/C
287 226 €
388 923 €
364 853 €
344 540 €
Net margin
N/C
8.5%
14.5%
N/C
N/C
14.1%
13.9%
13.5%
12.3%
Revenue and income statement
In 2024, PHARMACIE FUGERAY - PAGE generates positive net income of 170 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 324 k€ -> 170 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
169 807 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 575%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 13%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
575.464%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
12.75%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
534.824
386.71
331.261
411.762
275.393
443.703
459.151
892.716
575.464
Financial autonomy
12.807
12.66
13.731
10.425
13.204
14.279
14.068
8.044
12.75
Repayment capacity
6.117
3.878
3.254
4.08
None
None
4.673
9.067
None
Cash flow / Revenue
10.857%
13.869%
14.514%
14.405%
None%
None%
14.419%
8.56%
None%
Sector positioning
Debt ratio
575.462024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average
In 2024, the debt ratio of PHARMACIE FUGERAY - PAGE (575.46) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
12.75%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch
In 2024, the financial autonomy of PHARMACIE FUGERAY - PAGE (12.8%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Repayment capacity
9.07 years2023
2022
2023
Q1: 0.95 years
Med: 3.59 years
Q3: 7.48 years
Average+16 pts over 2 years
In 2023, the repayment capacity of PHARMACIE FUGERAY - PAGE (9.07) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 88.71. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
128.861
35.498
26.975
23.748
18.098
58.128
55.589
71.356
88.714
Interest coverage
4.813
2.904
2.034
1.363
None
None
0.0
0.502
None
Sector positioning
Liquidity ratio
88.712024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Watch+8 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE FUGERAY - PAGE (88.71) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
0.5x2023
2022
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Average
In 2023, the interest coverage of PHARMACIE FUGERAY - PAGE (0.5x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE FUGERAY - PAGE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
247 206 €
-612 772 €
-708 841 €
-816 031 €
0 €
0 €
-107 254 €
39 191 €
0 €
Inventory turnover (days)
20
20
18
22
0
0
18
15
0
Customer payment term (days)
5
7
7
10
0
0
7
8
0
Supplier payment term (days)
52
51
37
56
0
0
43
49
0
Positioning of PHARMACIE FUGERAY - PAGE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE FUGERAY - PAGE is estimated at
2 370 631 €
(range 1 650 870€ - 3 546 599€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1650k€2370k€3546k€
2 370 631 €Range: 1 650 870€ - 3 546 599€
NAF 5 année 2024
Valuation method used
Net Income Multiple
169 807 €
×
14.0x
=2 370 631 €
Range: 1 650 870€ - 3 546 600€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE FUGERAY - PAGE with other companies in the same sector:
Frequently asked questions about PHARMACIE FUGERAY - PAGE
What is the revenue of PHARMACIE FUGERAY - PAGE ?
The revenue of PHARMACIE FUGERAY - PAGE in 2023 is 2.7 M€.
Is PHARMACIE FUGERAY - PAGE profitable?
Yes, PHARMACIE FUGERAY - PAGE generated a net profit of 170 k€ in 2024.
Where is the headquarters of PHARMACIE FUGERAY - PAGE ?
The headquarters of PHARMACIE FUGERAY - PAGE is located in SOUPPES-SUR-LOING (77460), in the department Seine-et-Marne.
Where to find the tax return of PHARMACIE FUGERAY - PAGE ?
The tax return of PHARMACIE FUGERAY - PAGE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE FUGERAY - PAGE operate?
PHARMACIE FUGERAY - PAGE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart